I last reviewed Copart (CPRT) in this September 10, 2022 post at which time I disclosed the purchase of an additional 100 shares in the FFJ Portfolio. Following that purchase, my total CPRT exposure consisted of 450 shares. On November 4, 2022, CPRT initiated a 2-for-1 stock split thereby doubling my holdings to 900; the [...]
In my September 14 guest post at Dividend Power, I discuss how Nasdaq (NDAQ) is transforming future capital markets. I first reviewed NDAQ in this October 21, 2021 post at which time I decided not to initiate a position. On June 12, 2023, however, NDAQ announced that it entered into a definitive agreement to acquire [...]
In my August 16 Agilent Technologies (A) post, I disclosed the following purchases: 100 shares @ ~$115.96/share on June 9; the forward adjusted diluted PE level was ~20.6. 100 shares @ ~$118.48/share on July 6; the forward adjusted diluted PE level was ~21.1. With the recent weakness in A's share price, I deem A's valuation [...]
In my July 29 post, I reviewed RTX Corporation (RTX) following the release of Q2 and YTD2023 results. In releasing Q2 results, RTX informed the investment community that its Pratt & Whitney (P&W) operating segment identified microscopic contaminants in a metal used in part of the Geared Turbofan (GTF) engines that power Airbus' popular A320neo [...]
I last reviewed Thermo Fisher Scientific (TMO) in this August 2 post at which time Q2 and YTD2023 results had recently been released; I concluded shares were overvalued at ~$544. Following that post: TMO completed the CorEvitas acquisition I touched upon in my previous post. Novo Nordisk hired TMO to help fill the injection pens [...]
In my August 26 Rollins (ROL) post, I reference the company's $1.5B shelf registration. One of the purposes of this shelf registration was to provide the company with liquidity to help the Rollins family divest a portion of their holdings. I concluded that post by stating 'Although ROL shares are not inexpensive, I intend to [...]
I last reviewed Lockheed Martin (LMT) in this July 19 post at which time LMT had just raised its FY2023 adjusted diluted EPS guidance to ~$27.00 – ~$27.20 from the prior ~$26.60 - ~$26.90 guidance. Based on my assessment, I increased my exposure by 50 shares in one of the 'Core' accounts within the FFJ [...]
This FFJ Portfolio - August 2023 report is an overview of my recent investment activity. Relative to August 2022, the value of the FFJ Portfolio has fallen by ~$15,606 CDN and increased by ~$1,153,509 USD. The increase is attributed to my concerted effort to increase my exposure to high-quality US companies. Purchases In The FFJ [...]
HEICO Corporation has two classes of common stock (HEI and HEI.a). Both classes of shares are virtually identical in all economic respects except voting rights. The difference is that each HEI share is entitled to one vote per share while each HEI.a share is entitled to a 1/10 vote per share. This post focuses on [...]
In July 2022, Rollins (ROL) announced its Board had approved the company's 2023 CEO succession plan. In August 2022, ROL named a new CFO. Since such time, the quality of financial information has improved. I last reviewed ROL in this February 20, 2023 post at which time the company had just released its Q4 and [...]